Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Which Is Better Retirement Sp 500 Or Multi Asset compares core approaches to building a durable retirement portfolio under varying market conditions.
26,364 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Apple’s measured AI approach contrasts with Microsoft’s aggressive spending, signaling a shift in investor bets as th...
This article breaks down what to expect from the NESR 2026 earnings call, including key revenue drivers, profitabilit...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
A niche nuclear tech stock reported solid revenue gains, but a large fund reduced its holdings. Learn how to read the...
Micron stock just popped again as banks boosted targets and demand signals showed improvement. This guide breaks down...
OpenAI is moving toward a potential trillion-dollar IPO, with confidential SEC filings reportedly underway and a Sept...
A single platform now powers a large share of global digital infrastructure, triggering merger chatter and forcing in...
Cash flow from senior housing and warehouse REITs is holding steady even as refinancing costs rise. The payout outloo...
A handful of the nation’s most fervent sports markets chose not to bid for hosting World Cup games in 2026, citing fi...
U.S. lenders are accelerating cash returns to shareholders after stress tests and capital rules ease. JPMorgan, Bank ...